RxDoctor Payments Data

Paul Carter, MD

Allergy & Immunology · Chattanooga, TNNPI 1710972872

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.0% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AstraZeneca at 32.4% of the total. 2025 is the largest year on record at $2,290, more than ten times the $29 reported in 2020. That places this record below the midpoint for allergy & immunology clinicians in TN, where the typical reported total is $6,300.

$2,382in general payments, 2019–2025

Across 96 payments — averaging $24.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$771
  • CSL Behring$261
  • Sanofi$257
  • GSK$228
  • ARS Pharmaceuticals Operations, Inc.$193
  • Regeneron Healthcare Solutions, Inc.$162
  • plus $510 from 13 others

What the payments were for

  • Food & beverage$2,28796%
  • Education$954%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,382 in reported general payments places this provider in the 25th percentile of 79 allergy & immunology providers in Tennessee.

See all allergy & immunology providers in Tennessee

Medicare billing

Part B allowed, 2024
$933
Medicare patients
42
Services billed
76

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in Chattanooga

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →